EGFR and neoplasm: Furthermore, the differences of H3K36me3 cfChIP enrichment in EGFR‐WT and EGFR‐mutant tumours (Fig. 3C) reveal of cfChIP‐seq can be used to study gene expression patterns in NSCLC tumours of different molecular subtypes.